CTLT insider transactions

Group Pres. Pharma & Consumer Gennadios Aristippos returned 135,286 shares to the company and was granted 21,562 shares, closing all direct ownership in the company (SEC Form 4)

Group President, Biologics Mcerlane David returned 47,730 shares to the company and was granted 11,426 shares, closing all direct ownership in the company (SEC Form 4)

Chief Accounting Officer Hatzfeld Michael returned 16,676 shares to the company and was granted 3,144 shares, closing all direct ownership in the company (SEC Form 4)

SVP, Quality & Reg. Affairs Gunther Scott returned 52,573 shares to the company and was granted 12,938 shares, closing all direct ownership in the company (SEC Form 4)

SVP, General Counsel, CCO Ferraro Joseph Anthony was granted 14,265 shares and returned 38,232 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Stahl Jack L returned 47,984 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Ryan Michelle R returned 10,835 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Okey Stephanie returned 12,635 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Morel Donald E Jr returned 70,118 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Lucier Gregory T returned 36,914 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Damelio Frank A returned 12,635 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Classon Rolf A returned 47,984 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Carroll J Martin returned 32,734 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Barg Steven returned 12,374 shares to the company, closing all direct ownership in the company (SEC Form 4)

Director Barber Michael J returned 18,052 shares to the company, closing all direct ownership in the company (SEC Form 4)

President & CEO Maselli Alessandro returned 290,745 shares to the company and was granted 113,224 shares, closing all direct ownership in the company (SEC Form 4)

Pres. BioProduct Delivery, CoS Hopson Ricky returned 40,696 shares to the company and was granted 10,722 shares, closing all direct ownership in the company (SEC Form 4)

Executive Chair Greisch John J returned 147,462 shares to the company and was granted 33,530 shares, closing all direct ownership in the company (SEC Form 4)

SVP, Chief Financial Officer Masanovich Matti returned 148,166 shares to the company and was granted 71,691 shares, closing all direct ownership in the company (SEC Form 4)

SVP, Chief HR Officer Evoli Lisa returned 51,398 shares to the company and was granted 12,032 shares, closing all direct ownership in the company (SEC Form 4)

Director Ryan Michelle R sold $167,160 worth of shares (2,800 units at $59.70), decreasing direct ownership by 21% to 10,835 units (SEC Form 4)

Director Barg Steven was granted 4,663 shares, increasing direct ownership by 60% to 12,374 units (SEC Form 4)

Director Ryan Michelle R was granted 4,663 shares, increasing direct ownership by 52% to 13,635 units (SEC Form 4)

Director Okey Stephanie was granted 4,663 shares, increasing direct ownership by 58% to 12,635 units (SEC Form 4)

Director Damelio Frank A was granted 4,663 shares, increasing direct ownership by 58% to 12,635 units (SEC Form 4)

Director Barber Michael J was granted 4,663 shares, increasing direct ownership by 35% to 18,052 units (SEC Form 4)

Director Morel Donald E Jr was granted 4,663 shares, increasing direct ownership by 7% to 70,118 units (SEC Form 4)

Director Carroll J Martin was granted 4,663 shares, increasing direct ownership by 17% to 32,734 units (SEC Form 4)

Director Lucier Gregory T was granted 4,663 shares, increasing direct ownership by 14% to 36,914 units (SEC Form 4)

Director Classon Rolf A was granted 4,663 shares, increasing direct ownership by 11% to 47,984 units (SEC Form 4)

Director Stahl Jack L was granted 4,663 shares, increasing direct ownership by 11% to 47,984 units (SEC Form 4)

SVP, General Counsel, CCO Ferraro Joseph Anthony sold $19,190 worth of shares (320 units at $59.97), decreasing direct ownership by 1% to 23,967 units (SEC Form 4)

Group President, Biologics Mcerlane David sold $119,580 worth of shares (1,994 units at $59.97), decreasing direct ownership by 5% to 36,304 units (SEC Form 4)

Pres. BioProduct Delivery, CoS Hopson Ricky sold $39,429 worth of shares (662 units at $59.56), decreasing direct ownership by 2% to 29,974 units (SEC Form 4)

SVP, Quality & Reg. Affairs Gunther Scott sold $39,660 worth of shares (666 units at $59.55), decreasing direct ownership by 2% to 39,635 units (SEC Form 4)

SVP, General Counsel, CCO Ferraro Joseph Anthony sold $36,225 worth of shares (608 units at $59.58), decreasing direct ownership by 2% to 24,287 units (SEC Form 4)

SVP, Chief HR Officer Evoli Lisa sold $230,267 worth of shares (3,859 units at $59.67), decreasing direct ownership by 9% to 39,366 units (SEC Form 4)

Group Pres. Pharma & Consumer Gennadios Aristippos sold $69,614 worth of shares (1,169 units at $59.55), decreasing direct ownership by 1% to 113,724 units (SEC Form 4)

Executive Chair Greisch John J was granted 63,736 shares, increasing direct ownership by 394% to 79,932 units (SEC Form 4)

Chief Accounting Officer Hatzfeld Michael was granted 5,624 shares, increasing direct ownership by 71% to 13,532 units (SEC Form 4)

Group President, Biologics Mcerlane David was granted 18,746 shares, increasing direct ownership by 96% to 38,298 units (SEC Form 4)

SVP, General Counsel, CCO Ferraro Joseph Anthony was granted 17,042 shares, increasing direct ownership by 217% to 24,895 units (SEC Form 4)

SVP, Chief HR Officer Evoli Lisa was granted 15,338 shares, increasing direct ownership by 55% to 43,225 units (SEC Form 4)

SVP, Chief Financial Officer Masanovich Matti was granted 42,604 shares, increasing direct ownership by 126% to 76,475 units (SEC Form 4)

President & CEO Maselli Alessandro was granted 98,671 shares and sold $534,011 worth of shares (9,088 units at $58.76), increasing direct ownership by 102% to 177,521 units (SEC Form 4)

Pres. BioProduct Delivery, CoS Hopson Ricky was granted 10,225 shares and sold $12,086 worth of shares (206 units at $58.67), increasing direct ownership by 49% to 30,636 units (SEC Form 4)

SVP, Quality & Reg. Affairs Gunther Scott was granted 11,078 shares and sold $16,609 worth of shares (283 units at $58.69), increasing direct ownership by 37% to 40,301 units (SEC Form 4)

Group Pres. Pharma & Consumer Gennadios Aristippos was granted 18,746 shares and sold $20,486 worth of shares (349 units at $58.70), increasing direct ownership by 19% to 114,893 units (SEC Form 4)

SVP, Chief Financial Officer Masanovich Matti sold $169,823 worth of shares (2,993 units at $56.74), decreasing direct ownership by 8% to 33,871 units (SEC Form 4)

Hopson Ricky sold $76,023 worth of shares (1,401 units at $54.26), decreasing direct ownership by 6% to 20,617 units (SEC Form 4)

Gunther Scott sold $21,749 worth of shares (387 units at $56.20), decreasing direct ownership by 1% to 29,506 units (SEC Form 4)

Kreuzburg Christa covered exercise/tax liability with 523 shares, decreasing direct ownership by 3% to 18,283 units (SEC Form 4)

Hatzfeld Michael was granted 7,908 shares (SEC Form 4)

SEC Form 3 filed by new insider Hatzfeld Michael

Gennadios Aristippos was granted 1,505 shares and covered exercise/tax liability with 367 shares, increasing direct ownership by 1% to 96,496 units (SEC Form 4)

Maselli Alessandro was granted 3,761 shares and covered exercise/tax liability with 1,924 shares, increasing direct ownership by 2% to 87,938 units (SEC Form 4)

Gunther Scott was granted 1,023 shares and covered exercise/tax liability with 250 shares, increasing direct ownership by 3% to 29,893 units (SEC Form 4)

Hopson Ricky was granted 747 shares and covered exercise/tax liability with 256 shares, increasing direct ownership by 2% to 22,018 units (SEC Form 4)

Pravda Ricardo acquired 379 shares and disposed of 1,081 shares, decreasing direct ownership by 2% to 29,522 units (SEC Form 4) (Amendment)

Lickfold Charles disposed of 637 shares and acquired 190 shares, decreasing direct ownership by 4% to 10,892 units (SEC Form 4) (Amendment)